AMCP Submits Comments to FDA on BsUFA II Reauthorization
October 19, 2016
October 19, 2016
ALEXANDRIA, Va., Oct. 19 -- The Academy of Managed Care Pharmacy issued the text of the following letter:
Food and Drug Administration
Division of Dockets Management (HFA-305)
Department of Health and Human Services
5630 Fishers Lane
Room 1061
Rockville, MD 20852
Re: Biosimilar User Fee Act: Public Meeting; Request for Comments
[FDA-2015-N-3326-0012]
Dear Sir or . . .
Food and Drug Administration
Division of Dockets Management (HFA-305)
Department of Health and Human Services
5630 Fishers Lane
Room 1061
Rockville, MD 20852
Re: Biosimilar User Fee Act: Public Meeting; Request for Comments
[FDA-2015-N-3326-0012]
Dear Sir or . . .